Valuation: Ovation Science Inc.

Market Cap 1.15M 827K 717K 672K 612K 78.89M 1.17M 7.91M 3.09M 39.49M 3.1M 3.04M 132M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 978K 848K 795K 724K 93.32M 1.38M 9.36M 3.65M 46.71M 3.67M 3.59M 156M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-27.39%
1 week+366.67%
Current month+40.00%
6 months+65.09%
Current year+18.64%
1 month 0.01
Extreme 0.007
0.04
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0
Extreme 0.004
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-27.39%+366.67% - - 828K
+0.75%-1.36%+1.04%-7.03% 234B
+1.45%+0.17%+36.72% - 50.56B
+0.63%+11.75%+82.00% - 10.49B
+1.35%+7.86%+36.59%-45.62% 8.73B
-0.88%+2.44%+9.71%+3.14% 5.92B
-0.55%+0.39%-24.61%-30.93% 5.47B
-2.07%-2.46%-1.85%-15.38% 3.78B
-0.59%-0.63%-29.43%-46.19% 3.42B
+0.65%-1.91%-18.55%-48.97% 2.48B
Average -2.49%+0.39%+10.18%-27.28% 36.07B
Weighted average by Cap. +0.91%-1.45%+9.39%-9.60%

Financials

2024 2025
Net sales 113K 81.21K 70.39K 65.99K 60.17K 7.75M 115K 777K 303K 3.88M 305K 298K 12.94M 67.89K 48.7K 42.21K 39.57K 36.08K 4.65M 68.97K 466K 182K 2.33M 183K 179K 7.76M
Net income -456K -327K -284K -266K -242K -31.23M -464K -3.13M -1.22M -15.63M -1.23M -1.2M -52.15M -631K -453K -392K -368K -335K -43.22M -641K -4.33M -1.69M -21.63M -1.7M -1.66M -72.17M
Net Debt 265K 190K 165K 155K 141K 18.15M 269K 1.82M 710K 9.09M 714K 699K 30.31M 211K 151K 131K 123K 112K 14.43M 214K 1.45M 565K 7.22M 568K 555K 24.1M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
26-08-05 $0.007500 -79.67% 6,000